Foresee Pharmaceuticals CoROCO:6576 58 Days Payable is 44.21 as of Dec. 2025, which is 53% below its 10-year median of 93.30. GuruFocus rates ROCO:6576 with a GF Score™ of 58/100 and a GF Value™ of NT$96.69 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Foresee Pharmaceuticals Co ranks worse than 52.82% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Foresee Pharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Foresee Pharmaceuticals Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Foresee Pharmaceuticals Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Foresee Pharmaceuticals Co's Days Payable falls into.
Foresee Pharmaceuticals Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Foresee Pharmaceuticals Co (ROCO:6576) has a Days Payable of 44.21 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Foresee Pharmaceuticals Co and its competitors. This is 53% below median its historical median of 93.30. Over the past decade, Foresee Pharmaceuticals Co's Days Payable has ranged from 78.10 to 326.61. According to the industry distribution chart, Foresee Pharmaceuticals Co ranks #487 out of 922 companies in the Drug Manufacturers industry, placing it in the top 52.8%.
Is Foresee Pharmaceuticals Co's Days Payable too high?
Foresee Pharmaceuticals Co's current Days Payable of 44.21 is 53% below median its 10-year median of 93.30. Over the past 10 years, this metric has ranged from a low of 78.10 to a high of 326.61. The Drug Manufacturers industry median Days Payable is 90.46. Foresee Pharmaceuticals Co's value of 44.21 is 51.1% below this industry median. Based on the distribution chart, Foresee Pharmaceuticals Co ranks #487 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Foresee Pharmaceuticals Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Foresee Pharmaceuticals Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Foresee Pharmaceuticals Co ranks #487 out of 922 companies for Days Payable. This places Foresee Pharmaceuticals Co in the lower half of its industry. The industry median Days Payable is 90.46. Foresee Pharmaceuticals Co's value of 44.21 is 51.1% below this benchmark. Historically, Foresee Pharmaceuticals Co's own Days Payable has ranged from 78.10 to 326.61 over the past decade. While the company's 10-year median is 93.30 vs. the industry median of 90.46, Foresee Pharmaceuticals Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.46, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Foresee Pharmaceuticals Co's current Days Payable of 44.21 is 51.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Foresee Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Foresee Pharmaceuticals Co's current Days Payable is 44.21, which is 53% below median its own 10-year median of 93.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Foresee Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co (ROCO:6576) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.69, compared to a current price of NT$83.10 — trading 14.1% below its estimated fair value. The current Days Payable is 44.21, which is 53% below median its 10-year median of 93.30 and 51.1% below the Drug Manufacturers industry median of 90.46. Foresee Pharmaceuticals Co's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Foresee Pharmaceuticals Co (ROCO:6576), the current Days Payable is 44.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Foresee Pharmaceuticals Co (ROCO:6576) Overvalued in 2026?
Based on GuruFocus' analysis, Foresee Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$83.10 is trading 14.1% below its estimated GF Value™ of NT$96.69.
GuruFocus considers Foresee Pharmaceuticals Co to be Modestly Undervalued.
Key valuation signals for ROCO:6576:
Days Payable: 44.21 (53% below median its 10-year median of 93.30)
GF Value™: NT$96.69 vs. price of NT$83.10 (14.1% below fair value)
Industry Position: 51.1% below the Drug Manufacturers median (#487 of 922)
No single metric tells the full story. See the ROCO:6576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Foresee Pharmaceuticals Co Ltd main activity is applying stabilized injectable formulation (SIF) platform technology to produce products for anticancer and treatment of chronic diseases. Its pipeline includes CAMCEVI (Leuprolide, FP-001), FP-014 (Triptorelin), Aderamastat (FP-025, MMP-12 Inhibitor), Linvemastat (FP-020, MMP-12 Inhibitor), and others. The Group operates business only in a single industry of new drug development, and all of its revenue is generated from Taiwan.
58GF Score
Get the complete analysis for ROCO:6576
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6576 has been successfully added to your 
